Description

• Title:
  Is physical activity still the key to treating obesity? - semaglutide, a new position among therapies
• Creator:
  Makowska, Karolina;
  Billewicz, Marta;
  Marczyk, Aleksandra;
  Lis, Laura
• Description:
  Obesity is a condition characterized by excessive and abnormal accumulation of fat tissue. It disrupts energy homeostasis, leading to severe health problems. Physical activity is a significant part of reducing obesity. If sport activities are not enough, pharmacological management may be needed. One of pharmacological approaches to obesity treatment is a use of semaglutide. It is a glucagon-like peptide 1 receptor agonists (GLP-1RAs) approved for the treatment of type 2 diabetes. Semaglutide presents many pleiotropic effects and has an impact on several organ systems, such as cardiovascular, digestive, or nervous systems. Clinicals should remember about semaglutide’s complex mechanisms of actions and different adverse effects.
• Object availability:
  free access
• Rights: https://creativecommons.org/licenses/by-nc-sa/4.0 ;
  Prawa autorskie (c) 2024 Karolina Makowska, Marta Billewicz, Aleksandra Marczyk, Laura Lis
• Date:
  2024.08.28
• Type:
  info:eu-repo/semantics/article;
  info:eu-repo/semantics/publishedVersion
• Language:
  English
• Source:
  Quality in Sport; Tom 20 (2024); 54194;
  Quality in Sport; Vol. 20 (2024); 54194;
  2450-3118
• Format:
  application/pdf
• Publisher:
  University Center for Sports Research, Nicolaus Copernicus University, Torun, Poland
• Relation: https://apcz.umk.pl/QS/article/view/54194/39517
• Subject:
  semaglutide;
  GLP-1;
  sport;
  obesity;
  diabetes mellitus;
  activities
• Identifier: https://apcz.umk.pl/QS/article/view/54194
• Data provider:
  Akademicka Platforma Czasopism
• Can I use it?:
  seek permission
• Type:
  text